The research progress of lazertinib:a third-generation epidermal growth factor receptor tyrosine kinase inhibitor
HUANG Lu
LUO Meng-yu
WANG Zhi-feng
HONG Yi
Keywords:lazertinibepidermal growth factor receptor tyrosine kinase inhibitornon-small cell lung cancerclinical studyT790 M mutation
Publication Date:2023-07-15
Online Publishing Date:2026-08-14(First online date of this platform, not the publication date of the document)
Pages:7( 1302-1308 )
Chinese Journal of New Drugs

Chinese Journal of New Drugs

ISTICPKU
ISSN:1003-3734
Year, Vol.(Issue):2023,32(13)